Cresset Asset Management, LLC Astrazeneca PLC Transaction History

Cresset Asset Management, LLC

$17.3 Billion
Q4 2024

A detailed history of Cresset Asset Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cresset Asset Management, LLC holds 19,412 shares of AZN stock, worth $1.45 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

19,412

Previous 102,646 81.09%

Holding current value

$1.45 Million

Previous $8 Million 84.11%

% of portfolio

0.01%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$63.2 - $79.58 $5.26 Million - $6.62 Million	-83,234 Reduced 81.09%	19,412 $1.27 Million
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $541,903 - $619,298	7,068 Added 7.4%	102,646 $8 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $2.71 Million - $3.28 Million	40,565 Added 73.74%	95,578 $7.45 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $375,883 - $428,481	6,159 Added 12.61%	55,013 $3.73 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $334,763 - $374,735	-5,409 Reduced 9.97%	48,854 $3.29 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $408,165 - $451,279	6,294 Added 13.12%	54,263 $3.67 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $2.96 Million - $3.21 Million	42,304 Added 746.76%	47,969 $3.43 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $2,904 - $3,293	46 Added 0.82%	5,665 $393,000
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $248,769 - $323,249	-4,589 Reduced 44.95%	5,619 $380,000
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $15,216 - $38,960	-287 Reduced 2.73%	10,208 $560,000
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $194,965 - $234,050	-3,290 Reduced 23.87%	10,495 $683,000
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $442,082 - $532,530	-7,934 Reduced 36.53%	13,785 $913,000
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $318,555 - $376,405	-5,897 Reduced 21.35%	21,719 $1.27 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $850,901 - $930,998	15,315 Added 124.5%	27,616 $1.66 Million
Q2 2021 Aug 10, 2021	BUY	$48.42 - $60.18 $13,460 - $16,730	278 Added 2.31%	12,301 $737,000
Q1 2021 May 12, 2021	BUY	$47.16 - $54.44 $271,405 - $313,302	5,755 Added 91.82%	12,023 $598,000
Q4 2020 Feb 11, 2021	SELL	$48.52 - $58.02 $35,856 - $42,876	-739 Reduced 10.55%	6,268 $313,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $29,772 - $34,277	561 Added 8.7%	7,007 $384,000
Q2 2020 Aug 04, 2020	SELL	$43.1 - $55.31 $14,223 - $18,252	-330 Reduced 4.87%	6,446 $341,000
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $33,255 - $45,170	880 Added 14.93%	6,776 $303,000
Q4 2019 Feb 10, 2020	SELL	$42.46 - $50.46 $96,341 - $114,493	-2,269 Reduced 27.79%	5,896 $294,000
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $327,579 - $371,262	8,165 New	8,165 $364,000
Q2 2019 Aug 12, 2019	SELL	$37.28 - $41.68 $247,464 - $276,671	-6,638 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $107,037 - $129,748	3,016 Added 83.27%	6,638 $268,000
Q4 2018 May 21, 2019	BUY	$36.86 - $41.49 $133,506 - $150,276	3,622 New	3,622 $138,000

Others Institutions Holding AZN

# of Institutions

1,355

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $231B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Account

Cresset Asset Management, LLC Astrazeneca PLC Transaction History